AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.440
+0.010 (0.29%)
At close: Apr 9, 2026, 4:00 PM EDT
3.470
+0.030 (0.87%)
Pre-market: Apr 10, 2026, 4:08 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.04 billion as of April 9, 2026. Its market cap has increased by 38.33% in one year.
Market Cap
1.04B
Enterprise Value
652.26M
1-Year Change
38.33%
Ranking
Category
Stock Price
$3.44
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.04B, a decrease of -93.34%. That is a compound annual growth rate of -39.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 1.04B | 1.87% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 1.07B |
| MapLight Therapeutics | 1.06B |
| Inventiva | 1.04B |
| KalVista Pharmaceuticals | 1.03B |
| Xeris Biopharma Holdings | 1.01B |
| Annexon | 959.64M |
| Compass Therapeutics | 956.27M |
| CytomX Therapeutics | 929.56M |